Accelerating Cancer Immunotherapy Research

Business Services · Massachusetts, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

240 Sidney St Unit 203, Cambridge, Massa...

Phone Number

(978) 505-7507

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1

About Accelerating Cancer Immunotherapy Research

ACIR is dedicated to advancing cancer immunotherapy research by providing researchers with timely access to the latest literature in this rapidly evolving field. They offer free weekly digests, a comprehensive knowledge base, and a literature database to support researchers in their work. Their services are aimed at researchers and professionals in the cancer immunotherapy sector, helping to enhance creativity and productivity in the pursuit of effective treatments. ACIR's mission is to contribute to the ultimate goal of curing cancer through informed research and collaboration.Explore more
Accelerating Cancer Immunotherapy Research's Social MediaPopular SearchesAccelerating Cancer Immunotherapy ResearchThe Fritsch Foundation, Inc Dba AcirACIR.orgAcirSIC Code 87,873NAICS Code 54,541Show more

Accelerating Cancer Immunotherapy Research Org Chart

PhoneEmail
GL
United States flag for contact location.

Senior Communications & Outreach Coordinator

PhoneEmail
KT
United States flag for contact location.

Writer and Editor

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email
LH
United States flag for contact location.

Senior Scientific Writer and Illustrator

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Accelerating Cancer Immunotherapy Research your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Accelerating Cancer Immunotherapy Research

Compare insights from companies similar to Accelerating Cancer Immunotherapy Research, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Accelerating Cancer Immun...

<$5M
1-10
Private
-
2015
GL
Gaelle LlambiSenior Communications & Outreach Coordinator
$6.5M
11-50
Public
$340.5M
2015
JK
Justin KenkelDirector, Tumor Immunology and In Vivo Pharmacology
<$5M
1-10
Private
<$5M
2014
<$5M
11-50
Private
-
2015
<$5M
1-10
Private
$43M
2017
RA
Rossitza AlargovaVice President, Head of CMC
<$5M
1-10
Private
-
-
N/A
<$5M
1-10
Private
-
2018
David Genecov, President & Chief Executive Officer & Co-Founder at Dialectic Therapeutics
David GenecovPresident & CEO & Co-Founder
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Accelerating Cancer Immunotherapy Research is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Accelerating Cancer Immunotherapy Research is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Accelerating Cancer Immunotherapy Research.

Accelerating Cancer Immunotherapy Research Tech Stack

A closer look at the technologies used by Accelerating Cancer Immunotherapy Research

Accelerating Cancer Immunotherapy Research News & Media

Top Business Services Companies

Frequently Asked Questions Regarding Accelerating Cancer Immunotherapy Research

What is Accelerating Cancer Immunotherapy Research's official website?
Accelerating Cancer Immunotherapy Research's official website is www.acir.org
What is Accelerating Cancer Immunotherapy Research's Revenue?
Accelerating Cancer Immunotherapy Research's revenue is <$5 Million
What is Accelerating Cancer Immunotherapy Research's SIC code?
Accelerating Cancer Immunotherapy Research's SIC: 87,873
What is Accelerating Cancer Immunotherapy Research's NAICS code?
Accelerating Cancer Immunotherapy Research's NAICS: 54,541
How many employees does Accelerating Cancer Immunotherapy Research have?
Accelerating Cancer Immunotherapy Research has 1-10 employees
What industry does Accelerating Cancer Immunotherapy Research belong to?
Accelerating Cancer Immunotherapy Research is in the industry of: Business Services, Research & Development
What is Accelerating Cancer Immunotherapy Research competition?
Accelerating Cancer Immunotherapy Research top competitors include: Systems Oncology, Stelexis Therapeutics, Associazione Alan Ghitis, Bolt Biotherapeutics
What technology does Accelerating Cancer Immunotherapy Research use?
Some of the popular technologies that Accelerating Cancer Immunotherapy Research uses are: Cloudflare CDN, MailChimp, Google Font API, YouTube
How do I contact Accelerating Cancer Immunotherapy Research?
Accelerating Cancer Immunotherapy Research contact info: Phone number: (978) 505-7507 Website: www.acir.org
What does Accelerating Cancer Immunotherapy Research do?

ACIR is dedicated to advancing cancer immunotherapy research by providing researchers with timely access to the latest literature in this rapidly evolving field. They offer free weekly digests, a comprehensive knowledge base, and a literature database to support researchers in their work. Their services are aimed at researchers and professionals in... the cancer immunotherapy sector, helping to enhance creativity and productivity in the pursuit of effective treatments. ACIR's mission is to contribute to the ultimate goal of curing cancer through informed research and collaboration.Read More

What are Accelerating Cancer Immunotherapy Research social media links?
Accelerating Cancer Immunotherapy Research Linkedin page Accelerating Cancer Immunotherapy Research Twitter page Accelerating Cancer Immunotherapy Research Facebook page
Is Accelerating Cancer Immunotherapy Research a public company?
Accelerating Cancer Immunotherapy Research is private company therefore does not currently have an official ticker symbol
See more information about Accelerating Cancer Immunotherapy Research

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.